Skip to content

Preventing Infections After Cancer Surgery using Hypochlorous acid

Efficacy Of Hypochlorous Acid-Based Peritoneal Lavage In Reducing Surgical Site Infections Following Oncologic Laparotomy: A Randomized Controlled Pilot Study - NIL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097872
Enrollment
60
Registered
2025-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R970- Elevated carcinoembryonic antigen[CEA]

Interventions

Intervention1: computer generated block randomization: Group A (Intervention arm): Intraoperative peritoneal lavage with 500 mL of stabilized hypochlorous acid solution after tumor resection and hemo

Sponsors

Aster CMI Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18 75 years undergoing elective oncologic laparotomy. ECOG performance status 0 2. Ability to provide informed consent.

Exclusion criteria

Exclusion criteria: Immunocompromised state (e.g., neutropenia, HIV). Perforation or gross fecal contamination at time of surgery.

Design outcomes

Primary

MeasureTime frame
Outcome Assessment Primary Outcome Incidence of SSIs CDC criteria 6 within 30 daysTimepoint: Primary Objective To compare the incidence of surgical site infections within 30 days after surgery between patients receiving hypochlorous acid wash and those receiving standard saline wash.

Secondary

MeasureTime frame
Secondary Outcomes- Classification & timing of SSIs Length of hospital stay 30 day morbidity Clavien Dindo classification Drain site infection rate Need for antibiotic escalation, readmission, or reoperation CRP or WBC trends, severity of SSI, length of hospital stay, adverse events. Timepoint: Secondary Objective To assess the severity superficial, deep, organ or space & time to onset of SSIs. To compare postoperative inflammatory markers CRP, WBC count between groups. To evaluate the length of hospital, stay & readmission rates. To assess safety & adverse events related to HOC 1 use

Countries

India

Contacts

Public ContactDr Ashwin K R

Aster CMI Hospital

ashwin.kr@asterhospital.in09916926532

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026